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Borrelia burgdorferi is the etiological agent of Lyme disease, a multisystemic, multistage, 
inflammatory infection resulting in patients experiencing cardiac, neurological, and
arthritic complications when not treated with antibiotics shortly after exposure. The 
spirochetal bacterium transmits through the Ixodes vector colonizing the dermis of a 
mammalian host prior to hematogenous dissemination and invasion of distal tissues 
all the while combating the immune response as it traverses through its pathogenic 
lifecycle. The innate immune response controls the borrelial burden in the dermis, but is 
unable to clear the infection and thereby prevent progression of disease. Dissemination 
in the mammalian host requires temporal regulation of virulence determinants to
allow for vascular interactions, invasion, and colonization of distal tissues. Virulence 
determinants and/or adhesins are highly heterogenetic among environmental B. 
burgdorferi strains with particular genotypes being associated with the ability to
disseminate to specific tissues and the severity of disease, but fail to generate cross-
protective immunity between borrelial strains. The unique motility of B. burgdorferi 
rendered by the endoflagella serves a vital function for dissemination and protection from 
immune recognition. Progress has been made toward understanding the chemotactic 
regulation coordinating the activity of the two polar localized flagellar motors and their 
role in borrelial virulence, but this regulation is not yet fully understood. Distinct states of 
motility allow for dynamic interactions between several B. burgdorferi adhesins and host 
targets that play roles in transendothelial migration. Transmigration across endothelial 
and blood–brain barriers allows for the invasion of tissues and elicits localized immune 
responses. The invasive nature of B. burgdorferi is lacking in proactive mechanisms to 
modulate disease, such as secretion systems and toxins, but recent work has shown 
degradation of host extracellular matrices by B. burgdorferi contributes to the invasive 
capabilities of the pathogen. Additionally, B. burgdorferi may use invasion of eukaryotic 
cells for immune evasion and protection against environmental stresses. This review 
provides an overview of B. burgdorferi mechanisms for dissemination and invasion 
in the mammalian host, which are essential for pathogenesis and the development of 
persistent infection.
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iNTRODUCTiON
Lyme disease, the leading tick-borne infection in the United 
States, occurs in multiple stages and is a multisystemic disease due 
to the etiologic agent Borrelia burgdorferi (1–4). This disease was 
first recognized during the 1970s when a cluster of rheumatoid-
like arthritis cases occurred in patients who were predominantly 
children in Lyme, Connecticut (5). Lyme disease has become 
a significant emerging infectious disease with the Centers for 
Disease Control (CDC) estimating approximately 300,000 new 
cases in 2013 in the United States (6). The spirochetal bacterium 
is transmitted when an Ixodes tick vector colonized with B. burg-
dorferi takes a blood meal on reservoir mammals, such as small 
rodents and birds, or accidental human hosts, resulting in the 
colonization of dermal tissue and develops into a localized infec-
tion (7). This earliest stage of Lyme disease is characterized by a 
painless bulls-eye rash, called an erythema migrans, experienced 
by approximately 70–80% of patients at the site of the tick bite 
(1–3). In the absence of the distinctive erythema migrans, Lyme 
disease can be difficult to diagnose due to non-specific flu-like 
symptoms including headache, neck stiffness, malaise, fatigue, 
myalgia, and fever. During localized infection, the number of B. 
burgdorferi cells increases in the dermal tissue in preparation for 
dissemination to sites of secondary colonization. Days to weeks 
after infection, B. burgdorferi progresses onto a disseminated 
stage when the pathogen travels away from the site of the tick 
bite through the bloodstream and/or lymphatic system to invade 
and colonize various tissues, such as the heart, synovial fluid of 
joints, and the nervous system. Patients can develop secondary 
erythema migrans at distal locations on the skin from the original 
site of infection. Late infection, the third stage of disease, develops 
months to years after exposure to B. burgdorferi and patients can 
experience different manifestations including neuroborreliosis, 
Lyme carditis, and/or arthritis. Following antibiotic treatment, a 
subset of patients continues to present with arthritic symptoms 
that has been designated postinfectious, antibiotic-refractory 
Lyme arthritis (8).
Borrelia burgdorferi is a gram-negative “like” bacterium that is 
a member of the Spirochaetaceae family known by its distinctive 
spiral morphology and motility propelled by the endoflagellum 
(9, 10). Motility of B. burgdorferi is essential for pathogenesis 
throughout the enzootic cycle, though swimming traits differ 
greatly in the Ixodes tick than that observed in the mammalian 
host (11, 12). The segmented genome of B. burgdorferi is unlike 
most bacterial pathogens consisting of a 910,725  bp linear 
chromosome along with up to 23 circular and linear plasmids 
ranging in size from 5 to 56 kb (13, 14). The borrelial genome 
is minimal in size relative to other bacterial pathogens but is 
also limited in genes annotated to encode metabolic capabilities, 
virulence, and defense mechanisms. The glycolytic pathway is 
the only complete metabolic pathway identified in the annotated 
genome while pathways for generating energy, amino acids, 
and lipid synthesis, to name a few, are noticeably incomplete or 
absent (15, 16). B. burgdorferi scavenges from its environment 
to fulfill basic needs for survival and the pathogen goes as far 
as incorporating host lipids into the outer membrane (OM) that 
could also serve as an evasion mechanism (17). The simple bilayer 
membrane structure and limited number of detoxification genes 
provides little protection to B. burgdorferi from the onslaught of 
the host immune response, specifically oxidative and nitrosative 
stress (17–22). Borrelial oxidative stress regulator (BosR) has 
been associated with regulating genes involved in combating 
oxidative stress and is important for establishing mammalian 
infection (23–31). A single superoxide dismutase (sodA) aids 
in the resolution of reactive oxygen species (ROS), but to date a 
functional catalase has not been identified (32, 33). The reduced 
form of coenzyme A (CoASH) has been shown to serve in the 
place of catalase in B. burgdorferi by reducing hydrogen peroxide 
(22). Dynamic temporal and spatial regulation of borrelial genes 
is crucial for successful colonization, dissemination, and invasion 
of B. burgdorferi in the tick vector and mammalian host (7, 34, 
35). Borrelial two-component pathways HK1/Rrp1 and Rrp2-
RpoN-RpoS in the tick vector and mammalian host, respectively, 
regulate genes with a variety of functions including metabolism, 
chemotaxis, antigenic variation, and adhesion (7, 34). B. burg-
dorferi gene regulation also contributes to immune evasion as 
it progresses through the different stages of murine infection by 
inducing the recombination events of an antigenic variation gene 
(vlsE) and the activation or repression of lipoprotein genes in a 
tissue specific and temporal manner (36). The lack of secretion 
systems or toxins limits the ability of B. burgdorferi to modulate 
the resulting inflammatory disease.
Escape of B. burgdorferi from the tick midgut to the hemo-
lymph during a blood meal is an important step for transmission 
through the salivary glands to a mammalian host providing the 
necessary environmental cues, such as temperature and pH, for 
adaptation (7, 34). B. burgdorferi gene regulation in response to 
environmental cues is the best characterized for the early local-
ized stage of infection, but much remains to be understood about 
the mechanisms for dissemination and invasion necessary for 
the later stages of Lyme disease (7, 35, 37). Dissemination is a 
necessary step in pathogenesis, and this process inhibits clearance 
by the immune system, but the specific mechanisms and host–
pathogen events that initiate and complete this stage of infection 
are not well understood. Invasion of B. burgdorferi allows the 
pathogen to reach immunoprotected niches in the mammalian 
host where the pathogen is not cleared, but induces inflammation. 
The intimate interaction between B. burgdorferi lipoproteins and 
vascular tissue, in particular with extracellular matrices (ECM), 
has been shown to be integral to borrelial pathogenesis (38–41). 
B. burgdorferi adhesin interactions with the ECM and/or require-
ments for mammalian infection have been thoroughly reviewed 
by several contributors in the field (38–40), but the specific roles 
for many of these adhesins in dissemination and/or invasion has 
not been evaluated, therefore, were not addressed in this review. 
The purpose of this review is to highlight the mechanisms utilized 
by B. burgdorferi for dissemination and invasion of tissues of 
human and reservoir host.
MORPHOLOGY, MOTiLiTY, AND 
CHeMOTAXiS ReGULATiON
A discussion of dissemination and invasion would be incomplete 
without briefly describing the unique morphology, motility, and 
FiGURe 1 | Borrelia burgdorferi motility and associated regulation. Motility of B. burgdorferi is driven by multiple flagellum in the periplasmic space that are 
comprised of an inner membrane anchored basal body, hook, and filament. Coordinated rotation of the flagellar motors drive the direction of swimming or causes 
flexing of the spirochete. A two component regulatory system controls the motility in response to chemoattractant signals through the membrane-bound 
chemoreceptor and methyl-accepting chemotaxis protein (MCP). A complex is formed between MCP, linker protein CheW, and histidine kinase CheA with the latter 
able to autophosphorylate and transfer the phosphate to response regulators CheY1, CheY2, and CheY3 resulting in distinct outcomes. Levels of CheY-P can be 
reduced by the phosphatase CheX that forms a complex with CheD and increases its activity. The borrelial proteins designated in gray are chemotaxis homologs 
that have not been characterized to date. BB0569 localizes to the poles of the cell near flagellar motors and influences motility, but its specific function is unknown. 
CheR and CheB are potential methyltransferase and methylesterase proteins, respectively, which may modify MCP. Modification of Xu et al. (54).
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chemotaxis of B. burgdorferi that has been previously thoroughly 
reviewed (10, 12, 42). B. burgdorferi is often referred to as a gram-
negative “like” bacterium because it is void of lipopolysaccharide 
(LPS) in its OM, but has a similar membrane organization. 
The unique helical shape of spirochetes is due to its composi-
tion of the lipid bilayer OM, a periplasmic space containing 
peptidoglycan and endoflagella, and a second lipid bilayer 
inner membrane (IM) forming the inner most compartment 
of the cell structure (also called the protoplasmic cell cylinder). 
B. burgdorferi cells are long in length and thin in diameter with 
dimensions of 10–20 µm and approximately 0.3 µm, respectively. 
We have limited knowledge about the role of peptidoglycan in 
the morphology and motility of B. burgdorferi, but recent work 
has demonstrated that the temporal and spatial regulation of 
peptidoglycan synthesis occurs separately from cell elongation 
and septum formation take place separately, thus potentially 
contributes to the unique cell shape (43). In the periplasmic 
space, a flagellum is attached to each pole then travels toward 
the midline of the cell and potentially overlaps with the 
flagellum anchored at the opposite end of the cell (10, 12). 
Multiple flagellum, ranging from 7 to 11 individual flagellum, 
cluster at the poles of the cell and arrange themselves into a 
ribbon to form the borrelial endoflagella that wraps around 
the periplasmic cylinder generating the characteristic helical or 
planar flat-wave morphology. The concealment of the flagella 
within the periplasmic space preventing recognition by the host 
innate immune response is a passive means of immune evasion 
by B. burgdorferi.
The intricacy of the borrelial cell structure and complexity 
of its motility program makes the accompanying regulation 
astoundingly complex. Motility of each flagella in the cluster 
requires the coordinated activities of the basal body, hook, and 
filament (10, 12) (Figure 1). The basal body includes the export 
apparatus (FliH and FliI), C-ring switch complex (FliG and 
FliM), MS ring (FliF), collar structure, FliL, rod (FliE), P-ring, 
and the motor stator (MotA and MotB). The export apparatus 
and C-ring are located on the cytoplasmic face of the IM and 
associates with the MS ring that is flanked by FliL and stator 
embedded in the IM. FliL is important for the orientation of 
the motor and localizes between the stator and rotor. MotB, a 
motor protein, is required for in vivo helical morphology and 
motility (44). The rod extends from the MS ring into the P ring 
4Hyde Borrelia burgdorferi Dissemination and Invasion
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prior to transitioning into the flagellar hook. The rod and P-ring 
flank the collar and genes involved in collar formation have not 
been identified in B. burgdorferi. Recently identified, FlbB is 
a novel flagellar motor protein that associates with the basal 
body to achieve the proper orientation of the flagella and collar 
assembly (45). The primary contributor to the flagellar hook is 
FlgE that connects to the filament composed of FlaA and FlaB 
that are exported by a SecA-mediated pathway and Type III 
flagellin-specific pathway, respectively (10, 12). Coordinated 
motility of polarized endoflagella is a complex process for 
directional swimming or non-directional flex modality of bor-
relial cells. Endoflagella anchored on opposite ends rotation 
is coordinated to drive swimming in a single direction by one 
flagella moving clockwise and the second counterclockwise. 
Reversal of swimming occurs when both endoflagella change 
direction of rotation. The non-directional mode of motility 
occurs when the both endoflagella move in a clockwise or 
counterclockwise rotation resulting in a flex state that is similar 
to the tumble pattern of movement observed for other bacteria 
(46). B. burgdorferi motility in conventional liquid cultivation 
is widely homogeneous with the cells in a constant swim state. 
However, the in  vivo environments in which the pathogen 
traverses throughout the enzootic cycle are rarely consistent. 
In vitro cultivated B. burgdorferi in a media complex with 3% 
gelatin displayed heterogeneous motility patterns not unlike 
that observed in mammalian dermis (47). Another morphology 
taken on by B. burgdorferi is a round body, also referred to as a 
cystic formation, which is a proposed reversible survival mode 
when under conditions of stress (48–53). The mechanism for 
round body formation and the role of borrelial endoflagella in 
this process is unknown.
Borrelial motility is required for virulence, but more 
specifically is essential for the invasion of tissues in response 
to environmental signals (10, 12). A two-component signal 
transduction pathway regulates B. burgdorferi chemotaxis 
and utilizes a membrane-bound chemoreceptor and methyl-
accepting chemotaxis protein (MCP) that forms a complex 
with linker protein CheW and histidine kinase CheA to sense 
environmental cues (Figure  1). CheA autophosphorylates 
prior to transferring the phosphate to three response regula-
tors, CheY1, CheY2, and CheY3, encoded by B. burgdorferi. A 
low concentration of CheY-P initiates a run motility and high 
CheY-P concentrations causes B. burgdorferi to flex. CheX 
phosphorylase rapidly reduces the amount of CheY-P and is 
enhanced by forming a complex with CheD (55, 56). CheY3 is 
the only CheY response regulator that has a role in motility and 
CheY1 or CheY2 are not able to complement the function of 
CheY3 (57). Phosphorylated CheY3 interacts with the flagellar 
switch proteins to regulate the rotation of the motors. Xu et al. 
recently demonstrated a requirement of CheY2 for infectivity. 
However, this protein does not play a role in chemotaxis or 
motility (54). B. burgdorferi encodes homologs for chemotaxis 
adaptation proteins CheB and CheR, but to date, these proteins 
have not been characterized. In E. coli, CheR and CheB alter 
the methylation of MCP by methyltransferase and methylester-
ase activity, respectively, in response to positive and negative 
stimuli (46). The number of chemotaxis homologs encoded 
in the B. burgdorferi genome is greater and far more complex 
than other motile pathogens, such as E. coli or S. enterica (13, 
14). Additional genes, csrA and bb0569, influence the motility 
regulation of B. burgdorferi (58, 59). Carbon storage regulator, 
CsrA, is involved in posttranscriptional regulation of flagellar 
genes and contributes to cell morphology (59, 60). BB0569, 
annotated as a hypothetical protein, has sequence similarity to 
MCPs and was found to localize to the poles of the borrelial cell 
and important for motility and chemotaxis (58). B. burgdorferi 
motility is regulated throughout the enzootic cycle with the dis-
tinct behavior of intermittent swimming in the tick vector that 
includes periods of a non-motile state relative to the persistent 
swimming observed in the murine host (44, 61).
DiSSeMiNATiON
Borrelia burgdorferi disseminates from the site of the tick bite 
within the mammalian host to secondary colonization sites 
requiring dramatic adaptation of the pathogen in response to 
environmental changes and obstacles presented by the host 
innate immune response (7, 62–65). A bottleneck occurs during 
the B. burgdorferi initial colonization of dermal tissue when 
establishing localized infection. This process is in part mediated 
through the MyD88 pathway, which potentially alters the spiro-
chetal population progressing into the dissemination stage when 
it infects distal tissues (66–70). B. burgdorferi dissemination in 
mammals occurs by hematogenous and non-hematogenous 
routes, such as through the lymphatic system or direct spread 
through the tissues, with the former being the most well under-
stood (71, 72). B. burgdorferi hematogenous dissemination has 
been the focus of much research identifying distinct infectivity 
classifications of environmental or human isolates by the ribo-
somal spacer type (RST) or ospC sequence heterogeneity (73). 
Three RST genotypes have been defined for B. burgdorferi as 
RST1, RST2, and RST3 in descending order of dissemination 
capabilities (71, 74). At least 16 different ospC genotypes that 
vary in the ability to disseminate and cause disease have been 
recognized (73, 75–80). More human infections have been 
associated with ospC types A, B, I, H, and K, but there is no 
correlation with the frequency distribution of ospC genotypes in 
infected Ixodes scapularis (73, 81). Genotypes A and B are part 
of RST1, type I is in RST2 and H and K in RST3 (73). Genotypic 
differences can predict the ability of a B. burgdorferi strain to 
disseminate and cause infection. The effectiveness or lack of 
physical barriers, host factors, and immune response can also 
influence the outcome of borrelial infection.
B. burgdorferi Hematogenous vascular 
interactions
After the establishment of a localized dermal infection, B. burg-
dorferi begins to disseminate throughout the mammalian host 
via the hematogenous route (3, 71, 82). Borrelia hermsii, etiologic 
agent of relapsing fever, reaches high bacterial loads in the blood. 
However, B. burgdorferi, which also disseminates by hematog-
enous route, is difficult to isolate from blood due to the low num-
ber of bacterial cells present. The monitoring of bioluminescent 
B. burgdorferi in real time during murine experimental infection 
FiGURe 2 | Borrelia burgdorferi vascular interactions and transmigration. B. burgdorferi forms three types of vascular interactions: transient/tethering, 
dragging, and stationary adhesion. Decorin-binding protein A (DbpA) promotes transient/tethering with endothelial cells. Fibronectin-binding protein (BBK32) is 
involved in all three types of interactions. Stationary interaction through BBK32 may be through direct interaction with the endothelial surface or through a fibronectin 
bridge (Fn) to a host integrin. P66 also interacts with integrins and is important for transmigration of B. burgdorferi. Figure is a modification of Moriarty et al. (86).
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with an in vivo imaging system (IVIS) demonstrated the patho-
gen established a strong localized infection signified by elevated 
emission of light centered around the site of inoculation followed 
by dissemination throughout the skin (83). The inoculum dose 
altered the spatial and temporal dissemination of B. burgdorferi 
constitutively expressing codon-optimized firefly luciferase, but 
the general pattern of dissemination was the same independent 
of dose (83, 84). Upon reaching specific tissues or target sites, 
B. burgdorferi traverses dense extracellular matrix (ECM) and 
crosses tissue barriers through yet to be elucidated mechanisms.
Hematogenous dissemination of pathogens within mam-
mals is poorly understood due to the difficulty of evaluating 
bacteria under the shear stress conditions in the blood stream. 
Shear stress is a type of tangential stress that acts along a 
parallel surface due to friction caused by fluid viscosity that 
is overcome by bacteria for dissemination and invasion (85). 
The utilization of intravital microscopy (IVM) and spinning 
disk confocal intravital IVM allowed the evaluation of biofluo-
rescent B. burgdorferi in real time under in  vivo shear stress 
conditions that characterized the multiple stages of vascular 
interaction prior to transmigration (86–88). GFP-expressing B. 
burgdorferi visualized by IVM in murine ears approximately 
3–4 weeks after infection demonstrated swimming and flexing 
motility commonly observed under in  vitro cultivation (86). 
Microvascular interactions visualized in the murine skin flank 
by epifluorescence and spinning disk confocal IVM following 
intravenous injection of biofluorescent B. burgdorferi found 
that bacterial cells did not localize to arterioles, but localized 
to capillaries, postcapillary venules, and large veins. The study 
defined B. burgdorferi dissemination interactions as transient 
tethering-type associations, dragging interactions, and station-
ary adhesion (Figure  2). It is important to note that not all 
of the B. burgdorferi cells associated with the vasculature 
and thus were not directly assessed (86). Rapid extravasation 
of B. burgdorferi that did not form prior interactions was 
observed from postcapillary venules. Transient tethering-type 
interactions occurred briefly when B. burgdorferi slowed down 
relative to the velocity of the blood stream to associate with 
the endothelium at one region or tip of the cell in a manner 
that appeared to tether the cell to the surface followed by a 
detachment. Tethering stabilizes interactions by reducing the 
dissociation rates of B. burgdorferi from the endothelium 
(89). Dragging, another type of short-term interaction, was 
distinguished from tethering by B. burgdorferi coming into 
contact with the endothelium over the length of the cell and 
being dragged along the vascular surface in the direction of 
blood flow (86). The final stage of vascular interaction prior 
to transmigration is stationary adhesion where the B. burg-
dorferi cell is at a complete stop and no longer progressing in 
the direction of the blood stream. Borrelial cells maintained 
stationary adhesion for an average of 10 min. 3D visualization 
was performed to determine the localization of interactions in 
relation to endothelial junctions labeled with PECAM-1 that 
found stationary adhesion primarily occurred at the junctions 
while tethering and dragging took place along the endothelial 
cell surface (86). Non-infectious borrelial cells lacking genes for 
OM lipoproteins did not display the same interactions with the 
endothelium as infectious B. burgdorferi indicating pathogen 
ligands that can bind to specific host receptors (87). An in vitro 
flow chamber model was developed to evaluate B. burgdorferi 
interactions with human endothelia under a controlled environ-
ment for shear force (89). B. burgdorferi endothelial interactions 
in postcapillary venules by IVM and those in the flow chamber 
were consistent, thus providing an opportunity to understand 
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the specific mechanics behind tethering, dragging, and station-
ary adhesion in controlled conditions.
Numerous borrelial lipoproteins have previously been shown 
to bind components of the ECM (39, 41, 90–94). Norman et al. 
examined potential mechanisms mediating the interactions with 
the vasculature through fibronectin (Fn) and glycosaminoglycans 
(GAGs) (87). Biofluorescent B. burgdorferi was incubated with 
dextran sulfate to block potential GAG interactions and evalu-
ated in vivo by epifluorescence IVM resulting in a 30 and 80% 
reduction in transient and dragging interactions, respectively. 
Stationary adhesion was reduced to a similar level as dragging 
when cells were treated with dextran sulfate (87). This indicates 
that GAGs are involved in mediating the host–pathogen inter-
action of B. burgdorferi in the vasculature. The role of Fn in B. 
burgdorferi binding to the vasculature was assessed by treating 
B. burgdorferi that expresses fibronectin-binding protein, BBK32, 
with anti-Fn IgG prior to IV injection. Short-lived reduction in 
transient and dragging interactions were observed, suggesting 
that Fn plays an important role in the ability of B. burgdorferi 
to interact with the host vascular endothelium (87). Fibronectin 
C-terminal heparin-binding domain and integrin-interacting 
cell-binding domain that were responsible for B. burgdorferi 
vascular interaction was evaluated by competition with peptides 
representing the binding domains under in  vivo conditions. B. 
burgdorferi was able to readily interact with the endothelium at 
all stages when the RGD sequence of the integrin-interacting 
cell-binding domain was in circulation to compete with plasma 
Fn for binding. Heparin-binding domain peptide decreased B. 
burgdorferi transient interactions by 52% and further reduced 
dragging and stationary adhesion by 84%, suggesting that host 
GAGs are responsible the observed vascular interactions. The 
heparin-binding domain of Fn and GAGs are directly or indi-
rectly important for B. burgdorferi interactions with the host 
endothelial surface.
BBK32 is one of several B. burgdorferi proteins shown to bind 
Fn and its role in mammalian infectivity has been assessed as a 
ligand under in vivo conditions (83, 87, 88, 95–97). Fibronectin 
binding by B. burgdorferi may build a bridge for binding integrins 
allowing further host–pathogen interactions to occur (92, 98, 99). 
B. burgdorferi lacking bbk32 attenuates the infectivity phenotype 
and increases the ID50 about 15-fold as determined by cultiva-
tion of murine tissues 3 weeks after inoculation (95). High dose 
infection, specifically 105, with the bbk32 mutant strain results in 
colonization of disseminated tissues at a slightly lower level than 
wild-type when bacterial loads are quantitatively determined 
(97). In vivo imaging of bioluminescent bbk32 deletion strain 
demonstrated a similar dose dependent phenotype, but also that 
the role for bbk32 may be more important for earlier stages of 
infection (83). Light emission from mice infected with this strain 
was significantly less 1  week after inoculation when compared 
to wild-type infected controls. Gain-of-function experiments 
utilized non-infectious B. burgdorferi lacking several plasmids 
and an adhesin protein necessary for dissemination or invasion 
(86–88). Non-infectious B. burgdorferi that was complemented 
with bbk32 driven by the ospC promoter caused increased vascular 
interactions relative to the non-infectious parent strain lacking the 
transgene (87). Mutagenesis of bbk32 in infectious B. burgdorferi 
allowed the specific role of this fibronectin-binding protein to 
be characterized for Fn binding and vascular interactions (88) 
(Figure  2). Biofluorescent bbk32 deletion strain displayed a 20 
and 50% reduction in the murine skin flank and joint, respec-
tively, in tethering and dragging. Epifluorescence IVM requires 
a high dose inoculation by IV injection and may contribute to 
the different outcomes of bbk32 infectivity studies using lower 
dose intradermal inoculum that resulted in more pronounced 
virulence attenuation. The disruption of two regions of bbk32 
(Fn-binding, Δ158–182, or GAG-binding sequences, Δ45–68) 
caused a reduction of tethering and dragging, respectively, 
indicating these binding domains serve distinct mechanistic 
functions for B. burgdorferi endothelial interactions. BBK32 has 
a fast binding association and disassociation with Fn, but GAG 
binding is longer lasting and more stable (88). These differences 
in binding kinetics may explain the distinct binding interactions 
observed by in  vivo IVM. Flow chamber studies evaluated the 
specific mechanism by which BBK32 associates with the endothe-
lium and determined it contributes to stabilization of interactions 
and increases the range of force and shear stress through catch 
bond mechanism (89). A catch bond occurs when the higher the 
tensile force the longer the life of a non-covalent bond between 
a receptor and ligand (100). It is not clear if BBK32 is directly 
binding the endothelium utilizing lectin-binding sites or if the 
interactions are occurring through host ligands. Other possible 
fibronectin-binding proteins, RevA, RevB, and BB0347, were not 
able to restore vascular interactions in non-infectious B. burgdor-
feri (88). It is likely that a yet to be identified borrelial proteins that 
are able to bind fibronectin contribute to vascular interactions in 
addition to BBK32.
It is likely that many more players are involved in vascular 
interactions and possibly do so in a tissue specific or spatial man-
ner. A prime candidate is borrelial lipoprotein decorin-binding 
protein A (DbpA) that is able to bind decorin, heparin, and 
dermatan sulfate GAG (101–103). dbpA is co-transcribed with 
highly conserved dbpB that has a decreased decorin-binding 
ability and does not impact infection to the degree observed 
for dbpA (13, 14, 101, 104–106). Environmental signals, such as 
temperature, pH, and CO2, regulate dbpBA expression in a RpoS-
dependent manner (107–116). Incubation of B. burgdorferi with 
neuroglial or human umbilical vein endothelial cell (HUVEC) 
cells induced the expression of dbpBA among other virulence 
associated lipoproteins (117). B. burgdorferi lacking dbpBA has 
a severely attenuated infectivity phenotype with reduced coloni-
zation of the skin, heart, and joint when needle inoculated, but 
tick transmission of the dbpBA mutant resulted in an infectivity 
phenotype similar to wild-type (83, 118–122). Over time high 
dose inoculum of the dbpBA mutant can overcome the limitations 
to dissemination and reach wild-type bacterial burden in tissues 
despite reduced pathology in the heart and joint (118). Expression 
of dbpA is detectable up to 8 weeks after inoculation in several 
tissues, which is dissimilar to another RpoS-regulated gene ospC 
that is downregulated about a week after infection (123, 124). 
The importance of decorin binding by B. burgdorferi is further 
demonstrated in the resistance of decorin-deficient mice to infec-
tion (125). Transcripts of dbpA are readily detectable from blood 
during infection, but there is also some indication that DbpA 
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contributes to lymphatic dissemination of B. burgdorferi (118). 
The dbpBA mutant has reduced colonization of lymph nodes 
of immunocompetent mice relative to wild-type B. burgdorferi, 
but there was no difference observed in immunodeficient mice 
(118). The ability of DbpBA to aid in vascular interactions was 
assessed using an in vitro flow chamber seeded with HUVECs to 
mimic shear stress of the blood stream (126). Non-infectious B. 
burgdorferi B313 missing numerous plasmids was complemented 
with dbpBA on a shuttle vector and formed the short-lived tether-
ing interaction (126) (Figure 2). DbpA has not been evaluated 
under in vivo conditions with IVM. In addition, its specific con-
tribution to invasion as assessed by its ability to cross cell culture 
monolayers or to move in in vivo transmigration assays has not 
been determined. Vascular interaction is merely one step in the 
borrelial pathogenic process with stage each building upon the 
other for the end result of persistent infection in several mam-
malian tissues.
iNvASiON
Borrelial dissemination and subsequent invasion of mammalian 
tissues in the latter stages of disease is an essential step for patho-
genesis and immune evasion. Invasion of B. burgdorferi by enter-
ing into a tissue through transmigration or extravasation results 
in the colonization of secondary infection sites that become the 
foci of disease. B. burgdorferi has the ability to preferentially 
escape into heart or joint tissue and cross the blood–brain barrier 
(BBB) stimulating an inflammatory immune response to cause 
carditis, arthritis, and neuroborreliosis, respectively (1). The 
endothelial surface of the BBB has an unique organization and 
increased level of protection in comparison to other endothelial 
tissues targeted for invasion by B. burgdorferi. Invasion of the BBB 
by B. burgdorferi results in activation of the host plasminogen 
activation system (PAS), matrix metalloproteases (MMP), and 
host calcium signaling (127–129). It is likely that B. burgdorferi 
utilizes unique invasion strategies in a tissue-specific manner in 
addition to mechanisms common to other pathogens for entry 
into immunoprotected niches.
Early host–pathogen studies evaluated the ability of B. 
burgdorferi to cross cell culture monolayers of various types 
(130–135). Infectious B. burgdorferi is able to adhere and pen-
etrate through tight junctions from the apical surface to traverse 
the monolayer. This interaction with the host and subsequent 
transmigration is not without consequence as it can result in the 
enhanced response of neutrophils and T lymphocytes in HUVEC 
culture (136, 137). Evidence limited to in vitro studies indicate 
that B. burgdorferi has the ability to undergo intracellular inva-
sion of human fibroblast, umbilical vein endothelial, synovial, 
neuronal, and glial cells without the loss of viability (49, 133, 
138, 139). These findings lead to the speculation that borrelial 
cellular invasion is a mechanism for immune evasion and disease 
modulation, but the significance is unknown, as this has not 
been observed using an in vivo model system. Furthermore, an 
important effect of B. burgdorferi interacting with the host is the 
alteration of virulence determinants, including Dbp, OspA, and 
BBA64, which are important for mammalian infection (117, 140). 
The host–pathogen interactions and the resulting responses of B. 
burgdorferi and host tissue-specific pathways are important for 
the advancement of the spirochete into secondary colonization 
sites. The targeting of immunoprotective niches requires non-
specific and specific vascular interactions, as described above, 
followed by transmigration that is likely mediated by several 
distinct borrelial adhesins.
B. burgdorferi-elicited Transmigration 
in the Mammalian Host: The Role of P66
P66 (bb0603) is encoded on the borrelial chromosome and forms 
an OM β-barrel porin with adhesive capabilities to host integrins 
that contribute to mammalian infection (141–148). B. burgdor-
feri lacking P66 is able to persist in ticks through molting, but 
is unable to establish infection in the mammalian dermis and is 
cleared at the site of inoculation within 48 h following inoculation 
(149, 150). Expression of p66 is not observed in the tick vector 
until exposure to a blood meal and continues well into mam-
malian infection providing further support for the importance 
of P66 during mammalian infection. P66 engages the innate and 
adaptive immune response in the murine host as it is required 
for infection of mice deficient in the innate immune signaling 
molecules MyD88 and TLR-4 and elicits a specific antibody 
response against p66 expressing B. burgdorferi. A short-term 
infection model with intravenously infected Balb/c mice was used 
to evaluate the tissue localization of wild-type or p66 mutant B. 
burgdorferi 1 h after inoculation and resulted in a P66-dependent 
tissue tropism for the ear and heart (94). Disseminated B. burg-
dorferi requires specific adhesins dependent upon the tissue for 
colonization of distal sites.
The requirement for infectivity could be due to one or both of 
P66 identified functions: porin and/or integrin-binding activity. 
P66 was initially identified as an integral membrane porin in B. 
burgdorferi and was further shown to possess channel conduct-
ance (141, 142). Recent work by Kenedy et  al. characterized 
the β-barrel structure of P66 and found that it associates with 
lipoproteins OspA and OspB (143). The second identified func-
tion of P66 is its interaction with β1 chain and β3 chain integrins 
that are homodimeric proteins with the function of host cellular 
signaling and interactions with host cell matrices (147, 149, 
151, 152). Traditional mutational analysis and a phage-display 
screen verified β3 intergrin binding by P66 (147, 153). The 
specific binding region for integrin interaction was localized 
to amino acids 203–209 of P66 (151). Transcriptional analysis of 
human embryonic kidney cells and endothelial cells exposed to 
B. burgdorferi with or without p66 indicated significant changes 
among host genes involved in several pathways including cel-
lular interactions and actin arrangement indicating a potential 
role in pathogen invasion (152). Interaction of P66 with the 
host causing potential cellular arrangements may support the 
transmigration of the pathogen through tight junctions or pos-
sibly the intracellular invasion of B. burgdorferi. An in  vitro 
gentamicin protection study demonstrated B. burgdorferi utilizes 
β1 integrin to invade endothelial or fibroblast cells requiring 
the rearrangement of actin filaments and Src kinase activity 
(49). Internalized B. burgdorferi displayed the round body 
morphology previously observed when the pathogen is under 
stress conditions, but the change in shape could also be due 
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to spatial limitations within the host cell. At this time, the 
physiologic relevance of intracellular B. burgdorferi is unclear 
because evidence that this event also occurs during a natural 
infection has not been reported.
The requirement for borrelial P66 binding of host β3 integrin 
for infection in the murine experimental model was assessed 
by Ristow et al. (154). Mice expressing or devoid of β3 integrin 
had the same ID50 as wild-type B. burgdorferi and were also not 
infected by the p66 mutant strain, indicating that β3 integrin is 
not essential for infection and redundant integrin binding by 
borrelial cells may also support tissue invasion. Two p66 integ-
rin-binding targeted mutant strains were generated consisting 
of a regional deletion of amino acids 202 to 208 (BDel202-208) 
and double point mutation (BD205A,D207A). Phenotypes of 
the p66 targeted mutant strains were characterized for infectiv-
ity, in  vitro integrin binding, porin activity, and penetration 
of endothelial monolayers. BDel202-208 had an attenuated 
infectivity phenotype with significant reduced bacterial loads in 
the heart and tibiotarsal joint, while BD205A,D207A decreased 
in the heart relative to wild-type B. burgdorferi when mice 
were subcutaneously infected. Intravenous infection slightly 
alters the kinetics of borrelial infection and only BDel202-208 
had a reduced bacterial burden in the heart. BDel202-208 and 
BD205A,D207A significantly reduced αVβ3 integrin binding 
relative to wild-type, but did not disrupt channel conductance 
and maintained porin activity (147, 154). In correspondence 
with integrin binding, BDel202-208 and BD205A-D207A 
had an impaired ability to cross endothelial monolayer when 
compared to the wild-type strain. It is well established that P66 
and, more specifically, the region encompassing the integrin-
binding region is important for B. burgdorferi infection and 
possibly invasion. The route of host interaction is possibly 
through β1 integrin in addition to β3 integrin. β1 integrin could 
not be directly evaluated in vivo due to lethality associated with 
β1 deficiency.
The potential that P66 was involved in the dissemination 
or invasion of B. burgdorferi was evaluated by in vivo IVM for 
vascular interactions and in a newly developed high resolution 
intravital transmigration assay (155). Previous studies utilizing 
in vivo IVM focused on vascular interactions in the skin (86–88). 
Cd1d−/− mice are a preferred strain to examine B. burgdorferi 
infection in the joint because the lack of invariant natural killer 
T cells (iNKT) increases the bacterial burden and the likelihood 
of visualizing spirochetal vascular interactions or transmigration 
(156, 157). Kumar et  al. focused on the vascular interactions 
in joint proximal tissue of Cd1d−/− mice that were capable of 
recapitulating tethering, dragging, and stationary adhesion 
interactions of wild-type B. burgdorferi observed in murine skin 
(155). Spinning disk laser confocal microscopy captured a back 
and forth motility of B. burgdorferi as it transmigrates in the 
joint one day after high dose intravenous inoculation of Cd1d−/− 
mice (155). B. burgdorferi lacking p66 showed no difference in 
tethering, dragging, or stationary adhesion relative to wild-type. 
Therefore, this adhesive porin is not involved in vasculature 
interactions. Transmigration and clearance from the blood-
stream of p66 mutants was dramatically reduced when compared 
to wild-type or complemented p66 mutant strains raising the 
question whether the inability of B. burgdorferi to invade was 
due to clearance by the host immune response rather than the 
ability to cross the epithelial layer. Targeted p66 mutant strains 
were also not able to transmigrate, but interestingly, bloodstream 
clearance is at a similar rate to wild-type indicating that P66 
serves an active role in a borrelial transmigration mechanism. 
In vivo localization of β3 integrin in the vasculature in relation to 
B. burgdorferi was determined that P66-β3 integrin interaction 
associates with transmigration events at cellular junctions where 
stationary adhesion most often occurs. B. burgdorferi localized 
to areas in the vasculature with higher concentrations of β3 
integrin indicating this colocalization is taking place and con-
tributing to transmigration. Studies with β3 integrin-deficient 
mice showed B. burgdorferi was able to disseminate to various 
tissues, suggesting that β3 integrin binding is not the sole mecha-
nism for borrelial invasion. It is likely that the pathogen utilizes 
redundant invasion mechanisms through the binding of other 
integrins, such as β1, or host receptors. Active transmigration 
in the joint occurs above background levels 24 h after inocula-
tion, which may allow the time for activation of cell signaling 
pathways in endothelial cells and borrelial adaptation to support 
transmigration for successful invasion (158). The contribution 
of BBK32 to endothelial invasion, in addition to the previously 
noted vascular interactions, is determined not to be involved as 
the bbk32 mutant and wild-type B. burgdorferi displayed similar 
rates of transmigration. The role of P66 porin activity in vascular 
interactions, transmigration, and survival following epithelial 
invasion is unknown at this time. Taken together, P66 is involved 
in a potential invade-to-evade mechanism in B. burgdorferi that 
may have additional pathogenic functions (154, 155). Further 
studies are needed to elucidate possible P66 initiated actin and 
ECM rearrangements and the impact on the inflammatory 
response characteristic of Lyme disease.
B. burgdorferi Protease HtrA Role 
in invasion
The high-temperature requirement (HtrA) family of ATP-
independent serine proteases serve as chaperones, support 
membrane integrity by degrading damaged or improperly 
folded proteins, and pathogenesis by processing virulence 
determinants or degrading components of the ECM in other 
bacterial pathogens (159, 160). B. burgdorferi chromosomally 
encodes a single HtrA protease (BbHtrA) at bb0104 (13, 14). 
BbHtrA exhibits proteolytic activity and the potential of this 
protein to support borrelial pathogenesis and physiology was 
the subject of a MicroCommentary in Molecular Microbiology 
and a perspectives article in Frontiers in Cellular and Infection 
Microbiology (161–165). BbHtrA is a surface exposed protein 
that localizes to both the soluble and membrane fractions and can 
also form oligomeric structures (163, 164, 166). Production levels 
of BbHtrA are higher at 37°C relative to 34°C correlating with 
higher activity levels and induction during the stationary phase of 
in vitro cultivation conditions (167). It was the first HtrA in which 
proteolytic activity inhibited by zinc was described (166). Cell 
fission protein BB0323 is required for mammalian infection and 
proteolytically cleaved by BbHtrA demonstrating that B. burgdor-
feri is able to modify its own proteins (168). The B. burgdorferi 
FiGURe 3 | Proteolytic activity may promote Borrelia burgdorferi invasion of the extracellular matrix. B. burgdorferi (Bb) protease BbHtrA cleaves the 
family of hyalectin proteoglycans that includes hyalectin family of chondroitin sulfate proteoglycans, including aggrecan, brevican, neurocan, and versican. 
Specifically, BbHtrA protease activity degrades aggrecan (green lines) as indicated by dotted green line. This activity may contribute to ECM degradation and allow 
invasion of the pathogen. The presence of B. burgdorferi induces host matrix metalloproteases (MMP) from endothelial cells, chondrocytes, neutrophils, 
lymphoblast, and keratinocytes. Collagen (red lines) is degraded (dotted red line) by MMP-1 that is transcriptionally regulated along with MMP-3 through the JNK, 
mitogen-activated protein kinase, and JAK/STAT pathways.
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htrA mutant strain does not contain processed BB0323 at elevated 
temperatures validating the proteolytic function of BbHtrA 
in vivo (167). BbHtrA targets proteins for proteolysis that vary 
in function including cell fission (BB0323), chemotaxis (CheX), 
laminin binding (BmpD), and integrin binding (P66) (163, 168, 
169). Additional borrelial proteins are bound by BbHtrA without 
undergoing degradation, indicating that BbHtrA may also func-
tion as a chaperone (163). Transcripts of p66 in a borrelial strain 
overexpressing BbhtrA were reduced demonstrating another 
layer of regulation employed by this borrelial protease (169). The 
impact of BbHtrA on pathogenesis is widespread in regards its 
diverse mechanisms of regulation.
Another host target of borrelial proteolysis is aggrecan, 
which is a large aggregating proteoglycan found in cartilage 
with multiple functional domains consisting of two GAG-
attachment domains and three globular domains (170). Behera 
et  al. found that B. burgdorferi-induced aggrecanase 1 and 2 
(ADAMITS 4 and 5) in human chrondrocyte cells causes the 
cleavage of aggrecan, thus possibly explaining cartilage dam-
age associated with Lyme disease (171). The binding ability of 
B. burgdorferi aggrecan was attributed to borrelial GAG-binding 
protein (Bgp) (encoded by bb0588) and BbHtrA (164). The 
aggrecan interglobular domain (IGD), which resides between 
globular domains 1 and 2 (G1 and G2), is specifically cleaved 
by BbHtrA, thereby disrupting its ability to associate with GAG 
(164, 170). Proteolytic assays were performed to identify other 
host ECM proteins degraded by BbHtrA (165). The hyalectin 
family of chondroitin sulfate proteoglycans, including aggre-
can, brevican, neurocan, and versican, were also degraded by 
BbHtrA (Figure 3). Additional BbHtrA degraded ECM proteins 
were identified as fibronectin, biglycan, and decorin. B. burg-
dorferi is known to encode specific adhesins with the ability 
to bind these proteoglycans. Cell junction protein E-cadherin 
was only moderately degraded while collagen II and tenascin 
C were unaffected by incubation with recombinant BbHtrA. 
Together, these findings indicate that BbHtrA also has target 
specificity for degradation of host ECM. A point mutation was 
generated in the active site of BbHtrA, designated BbHtrAS226A, 
eliminating the protease activity and resulting in the loss of 
degradation of host ECM proteins (164, 165). The potential 
physiologic significance of BbHtrA proteolytic and chaperone 
activity was confirmed when Ye et  al. who generated an htrA 
deletion mutant strain that was not recoverable by cultivation 
from murine tissues two weeks following inoculation (167). It 
cannot be determined if the loss of infectivity was due to lack 
of proper borrelial protein processing through degradation and 
chaperone activity, a reduction in host ECM degradation that 
may inhibit invasion, or a compounding effect of both functions. 
The absence of htrA results in B. burgdorferi cells with in vitro 
growth deficiencies, cell membrane blebbing, and clustering 
of cells at elevated temperature when BbHtrA has the highest 
level of activity (167). These described in vitro phenotypes of B. 
burgdorferi would significantly impair infection if also observed 
in vivo. BbHtrA is highly immunogenic causing the stimulation 
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of inflammatory signaling and possibly causes further damage 
of the host ECM (164, 165). The immunogenicity of BbHtrA 
did not translate into protection against infection in the murine 
model (172). B.  burgdorferi may utilize the multifunctional 
BbHtrA to promote invasion through its ability to regulate and/
or process virulence determinants along with the degradation 
of the host ECM.
Induction of Host Proteases in Response 
to B. burgdorferi
Borrelia burgdorferi induction of aggrecanase activity was first 
observed in the synovial fluid of patients with Lyme arthritis and 
was thought to possibly be caused by host MMPs (173). MMPs 
are secreted zinc and calcium-dependent host proteases that 
act to remodel the ECM by specific degradation of aggrecan, 
collagen, elastin, fibronectin, and gelatin (174). MMPs aid in 
tissue growth, repair, and remodeling of healthy tissues. These 
host proteases also cleave chemokines, cytokines, and the 
accompanying receptors causing an inactivation or activation of 
these immunological molecules. The degraded ECM fragments 
released stimulate a localized inflammatory response similar to 
that observed in Lyme disease manifestations. B. burgdorferi 
induces a range of MMPs that are dependent upon the types 
of cell stimulated and infecting borrelial strain (173, 175–177). 
Human neutrophils, lymphoblast, and keratinocytes, secrete 
pro-MMP-9 when exposed to B. burgdorferi (175). HUVECs 
were able to release pro-MMP-9 and pro-MMP-2 under the 
same conditions. Borrelial infection induces the production of 
collagenase-1 (MMP-1), gelatinase-2 (MMP-2), stromelysin-1 
(MMP-3), and gelatinase B (MMP-9) in synovial fluid from 
patients with erythema migrans in addition to aggrecanase acti-
vation (173, 178) (Figure 3). The aggrecanase activity observed 
in synovial fluid of Lyme disease patients was found not to be 
associated with the stimulated MMP-2, MMP-3, or MMP-9, but 
may have been due to the more recently characterized BbHtrA 
activity described above (173). Cartilage explants from rhesus 
monkey and bovine were used as an in  vitro model of Lyme 
arthritis and incubation with B. burgdorferi resulted in cartilage 
degradation that was prevented in the presence of MMP inhibi-
tors (173). This could provide an explanation for the damage 
observed with Lyme arthritis and shed light on mechanisms 
utilized by B. burgdorferi for invasion and modulation of disease. 
The B. burgdorferi-induced profile of MMPs is specific to the 
tissue type and host species (173, 175). It was shown that both 
similarities and differences exist in the types of MMPs induced 
by B. burgdorferi in mice and humans and could be the reason 
for differences in susceptibility to borrelial infection and the 
development of arthritis. Different MMPs activated in response 
to B. burgdorferi are regulated through distinct host pathways 
(179–181). Specifically, MMP-1 and MMP-3 are regulated 
through c-Jun N-terminal kinase (JNK), p38 mitogen-activated 
protein kinase (MAPK), and Janus kinase/signal transducer 
and activation of transcription (JAK/STAT) pathway (179) 
(Figure  3). MMP-1, MMP-3, and MMP-9 regulation occurs 
through toll-like receptor 2 (TLR-2) (180, 181). MMP-1 and 
MMP-3 are also induced through the interaction of borrelial 
cells with α3 integrins (181). B. burgdorferi may utilize MMPs 
to manipulate ECM remodeling to promote invasion of the 
pathogen for secondary colonization of tissues with the diversity 
of induced MMPs and regulatory pathways ensuring progression 
of disease.
The idea that MMPs could promote invasion was supported 
by the increased transmigration of B. burgdorferi through ECM 
components under in  vitro conditions when incubated with 
MMP-9 (175). MMP-9 is able to cleave collagen type I and the 
resulting fragments chemoattract peripheral blood mononuclear 
cells; thus, this activity also elicits an immune response that could 
limit borrelial pathogenesis (182). The specific role of MMP-9 in 
B. burgdorferi invasion and inflammatory response under in vivo 
conditions is assessed by infecting MMP-9−/− mice and compar-
ing to wild-type mice in regards to bacterial burden, arthritis, and 
carditis. Murine hearts and joints were colonized at similar levels 
of bacterial burden indicating that MMP-9 alone is not responsi-
ble for invasion. This observation does not completely rule out the 
involvement of MMP-9 in aiding B. burgdorferi invasion of tissues 
through ECM remodeling. It is likely redundant mechanisms 
that are utilized to guarantee successful pathogenesis, which may 
occur through other MMPs or BbHtrA. Infected MMP-9−/− mice 
develop less arthritis relative to wild-type mice with an unexpected 
similarity in cytokine and chemokine expression, indicating that 
the ability of MMP-9 to modulate an inflammatory response is 
independent of B. burgdorferi infection. Further investigation of 
other MMPs individually or in combination is needed to fully 
understand the contribution of MMPs to B. burgdorferi invasion.
Plasmin has been observed in multiple studies to be activated 
by B. burgdorferi and is able to degrade ECM components and 
activate MMPs (173, 175, 183). The PAS, also referred to as the 
fibrinolytic system, involves the induction of a series of pro-
teases and accompanying regulatory inhibitors for the purpose 
of fibrin cleavage that support tissue remodeling, healing, and 
cell migration (129, 184). It was suspected that the activation 
of plasmin by the presence of B. burgdorferi could serve as a 
potential mechanism for spirochetal invasion. B. burgdorferi 
readily binds plasminogen and is converted to plasmin by host-
derived urokinase plasminogen activator (uPA) (38, 185, 186). 
This tightly regulated process is kept in check by plasminogen 
inhibitors type 1 and 2 (PAI-1 and PAI-2). Plasminogen binds 
B. burgdorferi through numerous identified receptors and pro-
motes the transmigration of the pathogen across HUVEC mon-
olayers (187). MMP-9 induction was observed in the presence 
of plasminogen when human PMBC cells were co-incubated 
with B. burgdorferi (175). During a tick blood meal, plasmino-
gen is activated, but is not required for borrelial transmission 
to a murine host (188). uPA is induced in monocytes of mice 
and humans in the presence of B. burgdorferi (189, 190). Hovius 
et  al. demonstrated that borrelia induces the PAS and, more 
specifically, showed that the receptor of uPA controls bacterial 
burden and promotes the phagocytosis of B. burgdorferi by leu-
kocytes (191). uPAR-deficient mice had increased B. burgdorferi 
colonization relative to the C56BL/6 wild-type mice. However, 
this increase was not observed in uPA, tPA, or PAI-1 knockout 
mice. In vitro phagocytosis assays display limited leukocyte 
phagocytosis in the absence of uPAR, but not the other mem-
bers of the PAS system. Therefore, the host PAS is not hijacked 
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by B. burgdorferi for ECM remodeling leading to the conclusion 
that this system does not contribute to invasion. However, this 
conclusion does not rule out the contributions of tick salivary 
glands or other supporting pathogenic mechanisms in mediat-
ing transmigration.
SUMMARY
The success of B. burgdorferi as a pathogen involves dynamic 
adaptation and interactions of specific tissues of the mam-
malian host with the pathogen during each stage of disease. B. 
burgdorferi engages numerous adhesins that are important for 
mammalian infection, but the specific contributions of these 
adhesins for dissemination or invasion are not fully elucidated. 
The specific mechanisms known to contribute to borrelial dis-
semination in the form of vascular interaction and invasion by 
transmigration under in vitro conditions or during mammalian 
infection has been the focus of this review. It is clear that B. 
burgdorferi is a resilient bacterium as it relies on redundant func-
tions for both dissemination and invasion to ensure progression 
of pathogenesis. This presents a challenge to clearly understand 
these mechanisms. Significant advances in our understanding 
of B. burgdorferi vascular interactions and invasion have been 
made through the development of in vivo imaging technologies 
allowing the identification of stages of interactions. Borrelial 
adhesins are responsible for interactions with the host that 
promote dissemination or invasion in a tissue specific manner. 
It is unclear the degree to which B. burgdorferi interaction with 
the endothelium can directly induce cellular rearrangement 
allowing for the invasion of host tissues. Furthermore, pathogen 
and host proteases combat a barrier to B. burgdorferi invasion by 
proteolytically cleaving the ECM.
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